ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Nonconventional induction strategies for production of recombinant human tumor necrosis factor-alpha in Escherichia coli

Tapan Kumar Singha, Pooja Gulati, Sanjay Kumar.



Abstract
Download PDF Cited by 6 ArticlesPost

The present study investigates the production kinetics of recombinant human tumor necrosis factor alpha (TNF-α) in Escherichia coli under three different non-conventional inducible expression systems viz. salt, the thermal and auto-inducible system in batch culture in a bioreactor. A codon-optimized synthetic gene of human TNF-α was inserted into plasmid pET-14b under T7 promoter to obtain its plasmid based expression in E. coli. Very high specific yields were obtained with auto-inducible expression systems ~47% of total cellular protein (TCP). The thermal and salt-induced expression could yield up to ~30% and ~17 % of TCP respectively. Maximum specific productivities were reported to be 0.092 g/gDCW/h, 0.1 g/gDCW/h, 0.079 g/gDCW/h for auto-inducible, thermal inducible, salt inducible expression systems respectively.

Key words: TNF-α, Expression kinetics, Auto-induction, Thermal induction, Salt induction, Escherichia coli







Bibliomed Article Statistics

32
18
35
25
29
47
43
21
21
21
23
14
R
E
A
D
S

22

14

10

14

11

53

15

10

6

11

9

7
D
O
W
N
L
O
A
D
S
010203040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.